Researchers Identify Gene That Reverses Cellular Aging

A study shows that activating the SRSF1 gene can slow frailty and extend lifespan in mice models.

Updated on Oct. 15, 2026 in Life Sciences

Researchers Identify Gene That Reverses Cellular Aging

Live Poll

Should medical research prioritize the development of new gene therapies to extend human lifespans?

Scientists have identified the SRSF1 gene as a key factor in reversing cellular aging and reducing chronic inflammation. By activating this gene, researchers successfully improved DNA repair functions and observed systemic anti-aging effects in treated mice.

Why it matters

This research provides a new pathway for developing therapies to delay aging while avoiding the risks associated with previous cell reversion techniques. The use of AI modeling allowed scientists to pinpoint this specific gene for its potential to restore cellular health safely.

The study observed that SRSF1 injection in aged mice increased median survival by 14% and slowed frailty progression by 44%. Researchers utilized an AI model to identify the gene, which is essential for processing genetic information for protein production.

The players

Harvard Medical School

This is a world-renowned medical research and educational institution based in Boston that frequently leads breakthroughs in clinical and cellular science.

Wyss Institute

The Wyss Institute is a cross-disciplinary research facility at Harvard University that focuses on bio-inspired engineering and advanced medical technologies.

The details

Using an AI model to analyze human skin cell gene activity, the research team identified SRSF1 as a viable target to reverse biological aging. Following this, researchers delivered the gene to aged mice via a viral vector, which primarily targeted the liver and triggered systemic anti-aging benefits.

In 2012, Shinya Yamanaka developed a cell reversion technique.
On October 14, 2026, the research team published their findings in Nature Aging.

The Big Picture

This discovery marks a significant departure from the four-gene cell reversion technique established by Shinya Yamanaka in 2012. By isolating a single gene, the research shifts the scientific paradigm toward more targeted and potentially safer interventions for aging-related cellular decline.

While this discovery remains in the research phase, it paves the way for future medical therapies aimed at treating age-related diseases. If proven effective in human trials, these findings could eventually lead to new treatments that enhance longevity and physical health in aging populations.

The takeaway

This study highlights the growing capability of AI to streamline the identification of complex genetic factors in aging research. Future developments will focus on safely adapting these gene delivery techniques for human therapeutic use.